In an adult patient without sulfa allergy, normal renal function, and not pregnant, which is the more appropriate empiric antibiotic for infectious diarrhea: amoxicillin or cotrimoxazole (trimethoprim‑sulfamethoxazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Cotrimoxazole is Superior to Amoxicillin for Infectious Diarrhea

For empiric treatment of infectious diarrhea in adults, cotrimoxazole (trimethoprim-sulfamethoxazole) is the better choice over amoxicillin, though neither is the preferred first-line agent according to current guidelines.

Guideline-Based Recommendations

The 2017 IDSA guidelines explicitly recommend fluoroquinolones (ciprofloxacin) or azithromycin as empiric therapy for adults with infectious diarrhea, not amoxicillin or cotrimoxazole 1. However, when forced to choose between these two options:

Why Cotrimoxazole Over Amoxicillin:

Cotrimoxazole demonstrates superior efficacy against the most common bacterial diarrheal pathogens, particularly Shigella species, which frequently show ampicillin resistance 2. In a head-to-head comparison:

  • All Shigella isolates were susceptible to cotrimoxazole in vitro 2
  • 73% of patients had culture-proven shigellosis, with 6 having ampicillin-resistant strains 2
  • Patients with ampicillin-resistant organisms treated with ampicillin showed clinical failure, while cotrimoxazole-treated patients responded well 2

The FDA-approved spectrum of cotrimoxazole specifically includes:

  • Shigella flexneri and Shigella sonnei 3
  • Enterotoxigenic E. coli (ETEC) causing bacterial gastroenteritis 3
  • Common urinary and respiratory pathogens that may cause systemic illness 3

Clinical Algorithm for Use:

Use cotrimoxazole when:

  • Empiric therapy is indicated per IDSA criteria (bloody diarrhea with fever, abdominal pain, dysentery syndrome) 1
  • Fluoroquinolones or azithromycin are unavailable or contraindicated
  • Local resistance patterns show ampicillin resistance is common 2, 4
  • Shigella or ETEC is suspected based on epidemiology 3

Avoid cotrimoxazole when:

  • Patient has sulfa allergy, G6PD deficiency, or severe renal/hepatic impairment 3
  • Pregnancy (use ceftriaxone instead) 5
  • AIDS patients (higher adverse event rates) 3

Critical Caveats and Safety Concerns

Cotrimoxazole carries significant adverse event risks that must be monitored 6:

  • 2.56-fold higher risk of rash compared to other antibiotics 6
  • 5-fold increase in Stevens-Johnson syndrome vs. azithromycin 6
  • 10-fold increase in drug reaction with eosinophilia and systemic symptoms (DRESS) 6
  • Hematologic toxicity: 10-fold increase in pancytopenia, 6-fold in neutropenia 6
  • Electrolyte disturbances: 56-fold increase in hyperkalemia, 10-fold in hyponatremia 6

Monitor closely for:

  • Skin reactions (discontinue immediately if rash develops) 3
  • Serum potassium, especially in elderly or those with renal dysfunction 3
  • Complete blood counts in prolonged therapy 3

Why Amoxicillin is Inadequate

Amoxicillin is not mentioned in IDSA guidelines for infectious diarrhea treatment 1 and shows:

  • High resistance rates (44% in one study) among Salmonella and Shigella 5
  • No specific FDA indication for bacterial gastroenteritis
  • Treatment failures documented in ampicillin-resistant infections 2

Optimal Real-World Approach

In actual clinical practice, neither drug should be first-line. The evidence strongly supports:

  1. First choice: Azithromycin (500mg day 1, then 250mg daily for 2-4 days) or ciprofloxacin (500mg BID for 3 days) 1
  2. Second choice (if above unavailable): Cotrimoxazole (800/160mg BID for 3-5 days) 2
  3. Avoid: Amoxicillin for empiric infectious diarrhea treatment

The key clinical decision point is whether empiric antibiotics are indicated at all 1:

  • Required: Bloody diarrhea + fever + severe illness/dysentery syndrome
  • Required: Recent international travel + fever ≥38.5°C
  • Not required: Mild watery diarrhea in immunocompetent patients

Recent data from Crete shows increasing Campylobacter prevalence with quinolone resistance, making azithromycin increasingly preferred over fluoroquinolones in some regions 4. Local antibiograms should guide final selection 1, 4.

References

5
Research

Characteristics of bacterial acute diarrhea among women.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016

Related Questions

What antibiotic regimen is recommended for acute diarrhea in an otherwise healthy adult with severe symptoms?
What are the adverse effects of trimethoprim-sulfamethoxazole (TMP‑SMX)?
In a patient allergic to sulfamethoxazole and trimethoprim, is there cross-reactivity with the sulfonylurea oral hypoglycemic glipizide?
What antibiotic is appropriate for acute watery diarrhea in an adult?
In a 75-year-old man with HIV and a low viral load who has had diarrhea for four days and has not responded to loperamide, should empiric oral antibiotics be initiated?
Does my 23‑month‑old child with a facial rash have erythema infectiosum (slapped‑cheek disease)?
Does ashwagandha (Withania somnifera) improve male fertility, and what are the proposed mechanisms of action?
In the 2026 LDL (low-density lipoprotein) guidelines, does the ASCVD (atherosclerotic cardiovascular disease) risk calculated with the Pooled Cohort Equations refer to the 10‑year risk or the 30‑year risk?
What baseline laboratory tests should be ordered for a patient with chronic kidney disease stage 3b?
In a patient with a known well‑differentiated neuroendocrine tumor who underwent microwave ablation of hepatic lesions, are heterogeneous, peripherally enhancing lesions in hepatic segments VII and V on a scan performed two months later consistent with expected post‑ablation changes or indicative of residual/metastatic disease?
What is the recommended workup and treatment for a maggot (myiasis) infestation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.